Adherence to combination prophylaxis for prevention of mother-to-child-transmission of HIV in Tanzania

PLoS ONE

Volumn 6, Issue 6, 2011, Pages

  Kirsten, Inga ^a   Sewangi, Julius ^b   Kunz, Andrea ^a   Dugange, Festo ^c   Ziske, Judith ^a   Jordan Harder, Brigitte ^a   Harms, Gundel ^a   Theuring, Stefanie ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^b MINISTRY OF HEALTH AND SOCIAL WELFARE   (Tanzania)

^c Kyela District Hospital   (Tanzania)

Author keywords

[No Author keywords available]

Indexed keywords

LAMIVUDINE; NEVIRAPINE; ZIDOVUDINE;

ADULT; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; FEMALE; GESTATION PERIOD; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFECTION PREVENTION; INFECTION RISK; MAJOR CLINICAL STUDY; MATERNAL AGE; OUTCOME ASSESSMENT; PATIENT COMPLIANCE; PLACENTAL TRANSFER; PUERPERIUM; RISK FACTOR; RURAL AREA; SINGLE DRUG DOSE; SOCIAL SUPPORT; TANZANIA; TREATMENT RESPONSE; VERTICAL TRANSMISSION; ADOLESCENT; DELIVERY; DISEASE TRANSMISSION; DRUG COMBINATION; HOSPITAL; HUMAN IMMUNODEFICIENCY VIRUS; MOTHER; PATHOGENICITY; PREGNANCY; RURAL POPULATION; STATISTICS; TIME;

ADOLESCENT; ADULT; DELIVERY, OBSTETRIC; DRUG THERAPY, COMBINATION; FEMALE; HIV; HIV INFECTIONS; HOSPITALS; HUMANS; INFECTIOUS DISEASE TRANSMISSION, VERTICAL; MOTHERS; PATIENT COMPLIANCE; PREGNANCY; RURAL POPULATION; TANZANIA; TIME FACTORS; YOUNG ADULT; ZIDOVUDINE;

EID: 79958742179     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0021020     Document Type: Article

References (49)

1. Joint United Nations Program on HIV/AIDS (UNAIDS) (2010) Global Report: UNAIDS report on the global AIDS epidemic 2010. WHO Library Catalogue-in-Publication Data. Available: http://www.unaids.org/globalreport/documents/20101123_GlobalReport_full_en.pdf. Accessed 10 April 2011.
2. De Cock KM, Fowler MG, Mercier E, de Vincenzi I, Saba J, et al. (2000) Prevention of mother-to-child HIV transmission in resource-poor countries: Translating research into policy and practice. JAMA 283: 1175-1182 doi:10.1001/jama.283.9.1175.
3. Guay LA, Musoke P, Fleming T, Bagenda D, Allen M, et al. (1999) Intrapartum and neonatal single-dose nevirapine compared with zidovudine for prevention of mother-to-child transmission of HIV-1 in Kampala, Uganda: HIVNET 012 randomised trial. Lancet 354: 795-802.
4. Stringer EM, Sinkala M, Stringer JSA, Mzyece E, Makuka I, et al. (2003) Prevention of mother-to-child transmission of HIV in Africa: successes and challenges in scaling-up a nevirapine-based program in Lusaka, Zambia. AIDS 17: 1377-1382 doi:10.1097/01.aids.0000060395.18106.80.
5. Dabis F, Bequet L, Ekouevi DK, Viho I, Rouet F, et al. (2005) Field efficacy of zidovudine, lamivudine and single-dose nevirapine to prevent peripartum HIV transmission. AIDS 19: 309-318.
6. Lallemant M, Jourdain G, Le Coeur S, Kim S, Koetsawang S, et al. (2000) A trial of shortened zidovudine regimens to prevent mother-to-child transmission of human immunodefiency virus type 1. N Engl J Med 343: 982-991 doi:10.1056/NEJM200010053431401.
7. Maga G, Amacker M, Ruel N, Hbscher U, Spadari S, (1997) Resistance to nevirapine of HIV-1 reverse transcriptase mutants: Loss of stabilizing interactions and thermodynamic or steric barriers are induced by different single amino acid substitutions. J Mol Biol 274: 738-747 doi:10.1006/jmbi.1997.1427.
8. Arrivé E, Newell ML, Ekouevii DK, Chaix ML, Thiebaut T, et al. (2007) Prevalence of resistance to nevirapine in mothers and children after single-dose exposure to prevent vertical transmission of HIV-1: A meta-analysis. Int J Epidemiol 36: 1009-1021 doi:10.1093/ije/dym104.
9. McIntyre JA, Hopley M, Moodley D, Eklund M, Gray GE, et al. (2009) Efficacy of short-course AZT plus 3TC to reduce nevirapine resistance in the prevention of mother-to-child HIV transmission: A randomized clinical trial. PLoS Med 6: e1000172 doi:10.1371/journal.pmed.1000172.
10. World Health Organization (WHO) (2006) Antiretroviral drugs for treating pregnant women and preventing HIV infection in infants: Towards universal access: Recommendations for a public health approach. 2006 version. Available: http://whqlibdoc.who.int/publications/2006/9789241594660_eng.pdf. Accessed 18 Sept 2010.
11. United Nations Development Programme (2008) Human Development Indices. Available: http://hdr.undp.org/en/media/HDI_2008_EN_Complete.pdf. Accessed 18 Sept 2010.
12. World Health Organization (2009) World Health Statistics. Available: http://www.who.int/whosis/whostat/EN_WHS09_Full.pdf. Accessed 18 Sept 2010.
13. Joint United Nations Program on HIV/AIDS (UNAIDS) (2004) United Republic of Tanzania: Epidemiological fact sheets on HIV/AIDS and sexually transmitted infections. Available: http://data.unaids.org/publications/Fact-Sheets01/tanzania_en.pdf. Accessed 18 Sept 2010.
14. The United Republic of Tanzania, Ministry of Health and Social Welfare (2007) Prevention of Mother-To-Child Transmission of HIV (PMTCT), National Guidelines Dar es Salaam, Tanzania Ministry of Health and Social Welfare.
15. World Health Organization (WHO) (2010) Antiretroviral drugs for treating pregnant women and preventing HIV infection in infants: Recommendations for a public health approach. 2010 version Geneva, Switzerland WHO Press Available: http://whqlibdoc.who.int/publications/2010/9789241599818_eng.pdf. Accessed 29 July 2010.
16. Gross R, Bilker WB, Friedman HM, Strom BL, (2001) Effect of adherence to newly initiated antiretroviral therapy on plasma viral load. AIDS 15: 2109-2117.
17. Garcia PM, Kalish LA, Pitt J, Minkoff H, Quinn TC, et al. (1999) Maternal levels of plasma human immunodeficiency virus type 1 RNA and the risk of perinatal transmission. N Engl J Med 341: 394-402 doi:10.1056/NEJM199908053410602.
18. Smith R, (2006) Adherence to antiretroviral HIV drugs: How many doses can you miss before resistance emerges? Proc Biol Sci 273: 617-624 doi:10.1098/rspb.2005.3352.
19. Karcher H, Kunz A, Poggensee G, Mbezi P, Mugenyi K, et al. (2006) Outcome of different nevirapine administration strategies in preventing mother-to-child transmission (PMTCT) programs in Tanzania and Uganda. J Int AIDS Soc 8: 12 doi:10.1186/1758-2652-8-2-12.
20. Tanzania Commission for AIDS (TACAIDS), National Bureau of Statistics (NBS), and ORC Macro (2008) Tanzania HIV & Malaria Indicator Survey 2007 Preliminary Report. Available: http://www.ihi.or.tz/docs/TzHIV-MalariaIndicatorSurvey-0708-PreliminaryReport.pdf. Accessed 18 Sept 2010.
21. World Health Organization (2007) Chronik HIV Care with ARV Therapy and Prevention. Available: http://www.who.int/hiv/pub/imai/Chronic_HIV_Care7.05.07.pdf. Accessed 18 Sept 2010.
22. Sikka R, Xia F, Aubert RE, (2005) Estimating medication persistency using administrative claims data. Am J Manag Care 11: 449-457.
23. Hall M, Frank E, Holmes G, Pfahringer B, Reutemann P, et al. (2009) The WEKA data mining software: An update. SIGKDD Explorations 11: 10-18 Software available: http://www.cs.waikato.ac.nz/~ml/weka/. Accessed 18 Sept 2010.
24. Chi BH, Cantrell RA, Zulu I, Mulenga LB, Levy JW, et al. (2009) Adherence to first-line antiretroviral therapy affects non-virologic outcomes among patients on treatment for more than 12 months in Lusaka, Zambia. Int J Epidemiol 38: 746-756 doi:10.1093/ije/dyp004.
25. Byakika-Tusiime J, Oyugi JH, TumwikirizeWA, Katabira ET, Mugyenyi PN, et al. (2005) Adherence to HIV antiretroviral therapy in HIV+ Ugandan patients purchasing therapy. Int J STD AIDS 16: 38-41 doi:10.1258/0956462052932548.
26. Mills EJ, Nachega JB, Buchan I, Orbinski J, Attaran A, et al. (2006) Adherence to antiretroviral therapy in sub-Saharan Africa and North America: A meta-analysis. JAMA 296: 679-690 doi:10.1001/jama.296.6.679.
27. Norman A, Chopra M, Kadiyala S, (2007) Factors related to HIV disclosure in 2 South African communities. Am J Public Health 97: 1775-1781 doi:10.2105/AJPH.2005.082511.
28. Brou H, Djohan G, Becquet R, Allou G, Ekouevi DK, et al. (2007) When do HIV-infected women disclose their HIV status to their male partner and why? A study in a PMTCT programme, Abidjan. PLoS Med 4: e342 doi:10.1371/journal.pmed.0040342.
29. Maman S, Medley A, (2004) Gender dimensions of HIV status disclosure to sexual partners: Rates, barriers and outcomes: A review paper. Available: http://www.who.int/gender/documents/en/genderdimensions.pdf. Accessed 29 July 2010.
30. Conkling M, Shutes EL, Karita E, Chomba E, Tichacek A, et al. (2010) Couples' voluntary counselling and testing and nevirapine use in antenatal clinics in two African capitals: A prospective cohort study. J Int AIDS Soc 13: 10 doi:10.1186/1758-2652-13-10.
31. Farquhar C, Kiarie JN, Richardson BA, Kabura MN, John FN, et al. (2004) Antenatal couple counseling increases uptake of interventions to prevent HIV-1 transmission. J Acquir Immune Defic Syndr 37: 1620-1626.
32. Theuring S, Mbezi P, Luvanda H, Jordan-Harder B, Kunz A, et al. (2009) Male involvement in PMTCT services in Mbeya Region, Tanzania. AIDS Behav 13 (Suppl 1): 92-102 doi:10.1007/s10461-009-9543-0.
33. Wouters E, Van Damme W, van Rensburg D, Meulemans Ha, (2008) Impact of baseline health and community support on antiretroviral treatment outcomes in HIV patients in South Africa. AIDS 22: 2545-2548 doi:10.1097/QAD.0b013e32831c5562.
34. Sarna A, Weiss E, (2006) Current research and good practice in HIV and AIDS treatment education. Available: http://unesdoc.unesco.org/images/0014/001497/149722e.pdf. Accessed 18 Sept 2010.
35. Nachega JB, Stein DM, Lehman DA, Hlatshwayo D, Mothopeng R, et al. (2004) Adherence to antiretroviral therapy in HIV-infected adults in Soweto, South Africa. AIDS Res Hum Retroviruses 20: 1053-1056 doi:10.1089/aid.2004.20.1053.
36. Mugusi F, Mugusi S, Bakari M, Hejdemann B, Josiah R, et al. (2009) Enhancing adherence to antiretroviral therapy at the HIV clinic in resource constrained countries; The Tanzanian experience. Trop Med Int Health 14: 1226-1232.
37. Nuwagaba-Biribonwoha H, Mayon-White RT, Okong P, Carpenter LM, (2007) Challenges faced by health workers in implementing the prevention of mother-to-child HIV transmission (PMTCT) programme in Uganda. J Public Health 29: 269-274 doi:10.1093/pubmed/fdm025.
38. Levy JM, (2009) Women's expectations of treatment and care after an antenatal HIV diagnosis in Lilongwe, Malawi. Reprod Health Matters 17: 152-161 doi:10.1016/S0968-8080(09)33436-9.
39. Government of Malawi, Ministry of Health (2008) Prevention of mother to child transmission of HIV and paediatric HIV care guidelines. Second Edition, July 2008. Government of Malawi. Available: http://www.aidstar-one.com/sites/default/files/PMTCT%20Guidelines%20Malawi%202008.pdf. Accessed 10 April 2011.
40. Government of Kenya, Ministry of Health (2009) Guidelines for prevention of mother to child transmission (PMTCT) of HIV/AIDS in Kenya. Third Edition, 2009. Available: http://www.aidstar-one.com/sites/default/files/PMTCT%20Guidelines%20Kenya%202009.pdf. Accessed 10 April 2011.
41. Karcher H, Omondi A, Odera J, Kunz A, Harms G, (2007) Risk factors for treatment denial an d loss to follow-up in an antiretroviral treatment cohort in Kenya. Trop Med Int Health 12: 687-694.
42. Tonwe-Gold B, Ekouevi DK, Viho I, Amani-Bosse C, Toure S, et al. (2007) Antiretroviral treatment and prevention of peripartum and postnatal HIV transmission in West Africa: Evaluation of a two-tiered approach. PLoS Med 4: e257 doi:10.1371/journal.pmed.0040257.
43. The Kesho Bora Study Group (2011) Triple antiretroviral compared with zidovudine and single-dose nevirapine prophylaxis during pregnancy and breastfeeding for prevention of mother-to-child transmission of HIV-1 (Kesho Bora study): A randomised controlled trial. Lancet Infect Dis 11: 171-180.
44. Meda N, Leroy V, Viho I, Msellati P, Yaro S, et al. (2002) Field acceptability and effectiveness of the routine utilization of zidovudine to reduce mother-to-child transmission of HIV-1 in West Africa. AIDS 16: 2323-2328.
45. WHO Global Data Bank on Infant and Young Child Feeding (IYCF) (updated 2009) Infant and young child feeding data by country, Tanzania. National Bureau of Statistics (NBS) and ORC Macro. Tanzania Demographic and Health Survey 2004-05. Available: http://www.who.int/nutrition/databases/infantfeeding/countries/tza.pdf. Accessed April 10 2011.
46. Grossberg R, Zhang Y, Gross R, (2004) A time-to-prescription-refill measure of antiretroviral adherence predicted changes in viral load in HIV. J Clin Epidemiol 57: 1107-1110 doi:10.1016/j.jclinepi.2004.04.002.
47. Weidle PJ, Wamai N, Solberg P, Liechty C, Sendagala S, et al. (2006) Adherence to antiretroviral therapy in a home-based AIDS care programme in rural Uganda. Lancet 368: 1587-1594 doi:10.1016/S0140-6736(06)69118-6.
48. Gill CJ, Hamer DH, Simon JL, Thea DM, Sabin LL, (2005) No room for complacency about adherence to antiretroviral therapy in sub-Saharan Africa. AIDS 19: 1243-1249.
49. Steiner J, Prochazka A, (1997) The assessment of refill compliance using pharmacy records: Methods, validity, and applications. J Clin Epidemiol 50: 105-116 doi:10.1016/S0895-4356(96)00268-5.